Insmed (INSM) News Today $66.36 -1.66 (-2.44%) Closing price 04:00 PM EasternExtended Trading$66.10 -0.27 (-0.40%) As of 05:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock INSM Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Insmed To Present at the 2025 Goldman Sachs Annual Global Healthcare ConferenceMay 28 at 7:10 AM | prnewswire.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $33.61 Million Stock Holdings in Insmed Incorporated (NASDAQ:INSM)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in Insmed Incorporated (NASDAQ:INSM - Free Report) by 15.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 486,847 shares of thMay 28 at 4:48 AM | marketbeat.comGF Fund Management CO. LTD. Makes New Investment in Insmed Incorporated (NASDAQ:INSM)GF Fund Management CO. LTD. purchased a new position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 3,756 shares of the biopharmaceutical company's stMay 27 at 4:57 AM | marketbeat.comTracking Stanley Druckenmiller's Duquesne Family Office Portfolio - Q1 2025 UpdateMay 27 at 12:39 AM | seekingalpha.comMan Group plc Trims Holdings in Insmed Incorporated (NASDAQ:INSM)Man Group plc decreased its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 95.3% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 28,963 shares of the biopharmaceutical company's stock after sellMay 26 at 3:58 AM | marketbeat.comFourth Dimension Wealth LLC Buys New Stake in Insmed Incorporated (NASDAQ:INSM)Fourth Dimension Wealth LLC bought a new stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 4,021 shares of the biopharmaceutical company's stock, valued at appMay 25 at 6:12 AM | marketbeat.comWoodline Partners LP Decreases Stake in Insmed Incorporated (NASDAQ:INSM)Woodline Partners LP decreased its holdings in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 25.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 162,230 shares of the biopharmaceutiMay 25 at 4:41 AM | marketbeat.comCastleark Management LLC Buys 9,480 Shares of Insmed Incorporated (NASDAQ:INSM)Castleark Management LLC raised its stake in Insmed Incorporated (NASDAQ:INSM - Free Report) by 21.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 52,780 shares of the biopharmaceutical company's stock after acqMay 24, 2025 | marketbeat.comHow Do Investors Really Feel About Insmed?May 23, 2025 | benzinga.comInsider Buying: Insmed Incorporated (NASDAQ:INSM) Director Buys 1,130 Shares of StockMay 23, 2025 | insidertrades.comInsmed Incorporated (NASDAQ:INSM) Shares Sold by Two Sigma Advisers LPTwo Sigma Advisers LP reduced its holdings in Insmed Incorporated (NASDAQ:INSM - Free Report) by 16.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 326,500 shares of the biopharmaceutical company's stMay 23, 2025 | marketbeat.comTwo Sigma Investments LP Has $41.01 Million Holdings in Insmed Incorporated (NASDAQ:INSM)Two Sigma Investments LP cut its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 25.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 593,996 shares of the biopharmaceutical compaMay 23, 2025 | marketbeat.comNationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. Invests $16.83 Million in Insmed Incorporated (NASDAQ:INSM)Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. acquired a new stake in Insmed Incorporated (NASDAQ:INSM - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 243,748 shares of the biopharmaceuticMay 22, 2025 | marketbeat.comProShare Advisors LLC Grows Stock Position in Insmed Incorporated (NASDAQ:INSM)ProShare Advisors LLC lifted its stake in Insmed Incorporated (NASDAQ:INSM - Free Report) by 43.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 56,991 shares of the biopharmaceutical company's stock after pMay 22, 2025 | marketbeat.comBrensocatib Shows Consistent Efficacy and Safety Across Three Prespecified Subgroups in New Data from Landmark ASPEN StudyMay 21, 2025 | prnewswire.comVestal Point Capital LP Sells 700,000 Shares of Insmed Incorporated (NASDAQ:INSM)Vestal Point Capital LP trimmed its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 43.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 900,000 shares of the biopharmaceutical company's stoMay 21, 2025 | marketbeat.comSoleus Capital Management L.P. Purchases 290,000 Shares of Insmed Incorporated (NASDAQ:INSM)Soleus Capital Management L.P. raised its holdings in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 958.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 320,272 shares of theMay 21, 2025 | marketbeat.comTema Etfs LLC Acquires Shares of 10,626 Insmed Incorporated (NASDAQ:INSM)Tema Etfs LLC acquired a new stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 10,626 shares of the biopharmaceutical company's stock, vaMay 20, 2025 | marketbeat.comPolar Asset Management Partners Inc. Sells 44,400 Shares of Insmed Incorporated (NASDAQ:INSM)Polar Asset Management Partners Inc. trimmed its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 77.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 13,100 shares of the biopharmaceutical coMay 20, 2025 | marketbeat.comInsider Selling: Insmed Incorporated (NASDAQ:INSM) Insider Sells 1,799 Shares of StockMay 20, 2025 | insidertrades.comNuveen Asset Management LLC Buys 205,473 Shares of Insmed Incorporated (NASDAQ:INSM)Nuveen Asset Management LLC boosted its stake in Insmed Incorporated (NASDAQ:INSM - Free Report) by 19.4% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,266,630 shares of the biopharmaceutical company's stock after acquiring an additionMay 20, 2025 | marketbeat.comMIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $7.27 Million Position in Insmed Incorporated (NASDAQ:INSM)MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in Insmed Incorporated (NASDAQ:INSM - Free Report) by 10.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 105,313 shares of the biopharmaceutical company'May 20, 2025 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Shares Sold by Suvretta Capital Management LLCSuvretta Capital Management LLC reduced its holdings in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 1.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,611,561 shares of the biopharmaceuticMay 19, 2025 | marketbeat.comRafferty Asset Management LLC Has $12.49 Million Stock Position in Insmed Incorporated (NASDAQ:INSM)Rafferty Asset Management LLC lowered its holdings in Insmed Incorporated (NASDAQ:INSM - Free Report) by 20.2% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 180,913 shares of the biopharmaceutical company's stock after sMay 19, 2025 | marketbeat.comRTW Investments LP Trims Stock Position in Insmed Incorporated (NASDAQ:INSM)RTW Investments LP lowered its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 7.9% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 3,014,558 shares of the biopharmaceutical company's stock after selling 257,450 shares during the perMay 18, 2025 | marketbeat.comPolar Capital Holdings Plc Buys 50,000 Shares of Insmed Incorporated (NASDAQ:INSM)Polar Capital Holdings Plc grew its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 7.4% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 730,000 shares of the biopharmaceutical company's stock after acquiring an additionalMay 17, 2025 | marketbeat.comMichael Alexander Smith Sells 409 Shares of Insmed Incorporated (NASDAQ:INSM) StockMay 16, 2025 | insidertrades.comMPM Bioimpact LLC Sells 225,780 Shares of Insmed Incorporated (NASDAQ:INSM)MPM Bioimpact LLC reduced its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 36.7% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 389,611 shares of the biopharmaceuticMay 16, 2025 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Shares Purchased by Patient Square Capital LPPatient Square Capital LP raised its stake in Insmed Incorporated (NASDAQ:INSM - Free Report) by 78.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 307,167 shares of the biopharmaceutical company's stMay 16, 2025 | marketbeat.comNWI Management LP Has $19.26 Million Position in Insmed Incorporated (NASDAQ:INSM)NWI Management LP increased its position in Insmed Incorporated (NASDAQ:INSM - Free Report) by 186.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 279,000 shares of the biopharmaceutical company's stock after buying an additional 181,460 shareMay 16, 2025 | marketbeat.comFY2025 EPS Estimates for Insmed Lifted by Cantor FitzgeraldInsmed Incorporated (NASDAQ:INSM - Free Report) - Equities researchers at Cantor Fitzgerald raised their FY2025 earnings per share (EPS) estimates for Insmed in a research report issued to clients and investors on Monday, May 12th. Cantor Fitzgerald analyst J. Kim now anticipates that the biopharMay 16, 2025 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Shares Sold by OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLCOCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC lessened its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 33.2% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 26,615 shares of the biopharmMay 16, 2025 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Position Boosted by Deutsche Bank AGDeutsche Bank AG raised its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 76.6% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 488,966 shares of the biopharmaceutical companyMay 16, 2025 | marketbeat.comJefferies Financial Group Initiates Coverage on Insmed (NASDAQ:INSM)Jefferies Financial Group began coverage on Insmed in a report on Tuesday. They issued a "buy" rating and a $105.00 target price on the stock.May 15, 2025 | marketbeat.comOrbimed Advisors LLC Buys Shares of 94,559 Insmed Incorporated (NASDAQ:INSM)Orbimed Advisors LLC acquired a new stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 94,559 shares of the biopharmaceutical company's stock, valued at apMay 15, 2025 | marketbeat.com22,289 Shares in Insmed Incorporated (NASDAQ:INSM) Bought by Baird Financial Group Inc.Baird Financial Group Inc. bought a new position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 22,289 shares of the biopharmaceutical compMay 15, 2025 | marketbeat.comBritish scientists find treatment for disease that contributed to Pope Francis’s deathMay 14, 2025 | msn.comInsmed's (INSM) "Buy" Rating Reaffirmed at HC WainwrightHC Wainwright restated a "buy" rating and issued a $90.00 price objective on shares of Insmed in a report on Monday.May 14, 2025 | marketbeat.comInsmed Incorporated (INSM): Among Small-Cap Healthcare Stocks Hedge Funds Are BuyingMay 14, 2025 | insidermonkey.comLion Point Capital LP Has $2.53 Million Position in Insmed Incorporated (NASDAQ:INSM)Lion Point Capital LP trimmed its holdings in Insmed Incorporated (NASDAQ:INSM - Free Report) by 29.7% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 36,700 shares of the biopharmaceutical company's stock after selling 15May 14, 2025 | marketbeat.comJefferies Initiates Coverage of Insmed (INSM) with Buy RecommendationMay 13, 2025 | msn.comEnsign Peak Advisors Inc Boosts Stake in Insmed Incorporated (NASDAQ:INSM)Ensign Peak Advisors Inc increased its holdings in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 9.3% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 529,049 shares of the biopharmaceutical company's stock aMay 13, 2025 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Given Consensus Rating of "Buy" by AnalystsInsmed Incorporated (NASDAQ:INSM - Get Free Report) has received an average recommendation of "Buy" from the sixteen analysts that are covering the stock, MarketBeat.com reports. Sixteen analysts have rated the stock with a buy recommendation. The average 1-year price objective among brokers thatMay 13, 2025 | marketbeat.com4INSM : Analyst Expectations For Insmed's FutureMay 12, 2025 | benzinga.comGranahan Investment Management LLC Reduces Stock Position in Insmed Incorporated (NASDAQ:INSM)Granahan Investment Management LLC decreased its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 3.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 209,354 shares of the biophMay 12, 2025 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Shares Bought by Driehaus Capital Management LLCDriehaus Capital Management LLC increased its stake in Insmed Incorporated (NASDAQ:INSM - Free Report) by 2.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 171,289 shares of the biopharmaceuticaMay 12, 2025 | marketbeat.comSchonfeld Strategic Advisors LLC Sells 49,672 Shares of Insmed Incorporated (NASDAQ:INSM)Schonfeld Strategic Advisors LLC reduced its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 85.7% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 8,260 shares of the biopharmaceutical company's stockMay 12, 2025 | marketbeat.comAnalysts Are Updating Their Insmed Incorporated (NASDAQ:INSM) Estimates After Its First-Quarter ResultsMay 12, 2025 | uk.finance.yahoo.comFred Alger Management LLC Trims Position in Insmed Incorporated (NASDAQ:INSM)Fred Alger Management LLC lowered its holdings in Insmed Incorporated (NASDAQ:INSM - Free Report) by 14.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 385,460 shares of the biopharmaceutical companyMay 11, 2025 | marketbeat.comFrontier Capital Management Co. LLC Sells 159,100 Shares of Insmed Incorporated (NASDAQ:INSM)Frontier Capital Management Co. LLC lowered its holdings in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 26.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 435,006 shares of the biopharmacMay 11, 2025 | marketbeat.com Get Insmed News Delivered to You Automatically Sign up to receive the latest news and ratings for INSM and its competitors with MarketBeat's FREE daily newsletter. Email Address INSM Media Mentions By Week INSM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INSM News Sentiment▼1.271.03▲Average Medical News Sentiment INSM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INSM Articles This Week▼1912▲INSM Articles Average Week Get Insmed News Delivered to You Automatically Sign up to receive the latest news and ratings for INSM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Takeda Pharmaceutical News Today Alnylam Pharmaceuticals News Today Beigene News Today Teva Pharmaceutical Industries News Today Summit Therapeutics News Today Royalty Pharma News Today Intra-Cellular Therapies News Today United Therapeutics News Today Genmab A/S News Today Dr. Reddy's Laboratories News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INSM) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredTrump’s Bitcoin Reserve is No Accident…For the first time in history, we have a president who understands crypto's potential to bypass the banking sy...Crypto 101 Media | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredDo You Believe In President Trump? Answer This 1 QuestionThey said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | Sponsored“You all just got a lot richer”Trump Knows What He’s Doing. When the president says he’s going to let RFK “go wild” … and Big Pharma crash...Brownstone Research | SponsoredUrgent: Make this trade before you hit your pillow tonight… Most people waste 8 hours every night… And 227,916 hours in their lifetime… Dreaming about the life they...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Insmed Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Insmed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy INSM Stock Free INSM Stock Alerts